Author Correction: Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate

Nat Genet. 2020 Sep;52(9):984. doi: 10.1038/s41588-020-0688-0.

Brett S Carver^{1

2}, Jennifer Tran¹, Anuradha Gopalan³, Zhenbang Chen^{1

4}, Safa Shaikh², Arkaitz Carracedo^{1

4}, Andrea Alimonti^{1

4}, Caterina Nardella^{1

4}, Shohreh Varmeh^{1

4}, Peter T Scardino², Carlos Cordon-Cardo⁵, William Gerald³, Pier Paolo Pandolfi^{6

7

8}

¹ Cancer Biology and Genetics Program, Sloan-Kettering Institute, New York, New York, USA.
² Department of Surgery, Division of Urology, New York, New York, USA.
³ Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
⁴ Cancer Genetics Program, Beth Israel Deaconess Cancer Center, Department of Medicine and Pathology, Harvard Medical School, Boston, Massachusetts, USA.
⁵ Department of Pathology, Columbia University, New York, New York, USA.
⁶ Cancer Biology and Genetics Program, Sloan-Kettering Institute, New York, New York, USA. ppandolf@bidmc.harvard.edu.
⁷ Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA. ppandolf@bidmc.harvard.edu.
⁸ Cancer Genetics Program, Beth Israel Deaconess Cancer Center, Department of Medicine and Pathology, Harvard Medical School, Boston, Massachusetts, USA. ppandolf@bidmc.harvard.edu.

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.